Skip to main
GRAL

GRAIL Inc (GRAL) Stock Forecast & Price Target

GRAIL Inc (GRAL) Analyst Ratings

Based on 4 analyst ratings
Buy
Strong Buy 50%
Buy 25%
Hold 25%
Sell 0%
Strong Sell 0%

Bulls say

GRAIL Inc. has experienced substantial stock appreciation of nearly 90% in the last month, highlighting a growing market confidence in its multi-cancer early detection technologies. The company's proprietary Total Addressable Market (TAM) analysis indicates a significant opportunity valued at approximately $3.7 billion in the UK by 2026, with potential growth to $4.0 billion by 2035, further bolstered by strategic partnerships to capture this market. Despite existing uncertainties around regulatory approvals and Medicare reimbursement, the positive data from the PATHFINDER 2 ESMO trial and a robust $400 million pending addition to GRAIL's balance sheet contribute to a favorable outlook for the company.

Bears say

GRAIL Inc has consistently reported substantial net losses since its inception, with expectations of ongoing losses as the company invests in studies, regulatory approvals, and expanding infrastructure. The firm faces significant risks that could impede its growth, including legislative delays obstructing reimbursement pathways, adoption challenges for its novel testing technology, and intense competition from established diagnostics companies with greater resources. Additionally, the anticipated increase in selling, general, and administrative expenses tied to Galleri volume growth, coupled with potential setbacks in clinical study timelines and financing challenges, further dampens the outlook for the company's operational and commercialization capabilities.

GRAIL Inc (GRAL) has been analyzed by 4 analysts, with a consensus rating of Buy. 50% of analysts recommend a Strong Buy, 25% recommend Buy, 25% suggest Holding, 0% advise Selling, and 0% predict a Strong Sell.

This aggregate rating is based on analysts' research of GRAIL Inc and is not a guaranteed prediction by Public.com or investment advice.

Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy

FAQs About GRAIL Inc (GRAL) Forecast

Analysts have given GRAIL Inc (GRAL) a Buy based on their latest research and market trends.

According to 4 analysts, GRAIL Inc (GRAL) has a Buy consensus rating as of Mar 21, 2026. This rating is provided by third-party analysts and is not investment advice from Public.com.

Wall Street analysts have set a price target of $88, reflecting a 0.00% increase from the current stock price.

Financial analysts have set a price target of $88, indicating a 0.00% increase from the current stock price, but ratings and forecasts are frequently updated based on market conditions, earnings reports, and industry trends. This prediction is provided by third-party analysts and is not investment advice from Public.com.

GRAIL Inc (GRAL)


Order type

Buy in

Order amount

Est. shares

0 shares

Sign up to buy
Disclaimer: Any investment listed here, which may be available on the Public platform, is intended to be used for informational purposes only, should not be the sole basis for making an investment decision, and is not a recommendation or advice.